+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting



Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting



American Heart Journal 147(6): 1071-1077



Levels of C-reactive protein (CRP), serum amyloid A protein (SAA), and interleukin-6 (IL-6) can predict coronary restenosis following angioplasty and stent deployment in patients with unstable angina. We investigated whether measurement of periprocedural inflammatory markers predicted the angiographic outcome at 6 months in stable angina patients undergoing coronary stenting. We prospectively studied 182 patients; 152 patients underwent elective and successful stenting procedure for de novo lesions in native and nongrafted coronary arteries and 30 individuals in the control group underwent diagnostic angiography alone. CRP, SAA, and IL-6 were determined by high-sensitivity immunoassays. At 6 months, quantitative computer-assisted angiographic analysis in 133 patients with stents showed a binary restenosis rate of 33.8%. Statins were being taken by 80% of the patients. There were no significant differences between the pre- or postprocedure values of CRP, SAA, or IL-6 in patients with or without in-stent restenosis. Preprocedural inflammatory markers in stable angina subjects undergoing coronary artery stent deployment did not correlate with the development of in-stent restenosis. Differences in pathobiology between stable and unstable coronary syndromes, the widespread use of statins with anti-inflammatory activity in our cohort of patients, along with different mechanisms underlying the early angiographic appearances of restenosis as compared to clinical end points, most likely explain our findings.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012444361

Download citation: RISBibTeXText

PMID: 15199358

DOI: 10.1016/j.ahj.2003.10.050


Related references

Preprocedural C-reactive protein levels are not associated with restenosis after successful coronary stenting Results from the GENERATION study. Journal of the American College of Cardiology 41(6 Supplement A): 65A-66A, March 19, 2003

Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting. Circulation Journal 69(12): 1477-1483, 2005

Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting. American Journal of Cardiology 98(3): 341-345, 2006

Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina. American Heart Journal 151(6): 1265-1270, 2006

Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase. Clinical Biochemistry 41(18): 1429-1433, 2008

Usefulness of preprocedural platelet aggregation to predict restenosis after percutaneous coronary intervention. American Journal of Cardiology 96(1): 71-73, 2005

Preprocedural creatinine clearance and long term survivalafter successful coronary stenting. Eurointervention 1(2): 208-213, 2005

Non-specific inflammatory markers and risk of restenosis after coronary stenting Relation to previous infection with chlamydia pneumoniae and treatment effect of roxithromycin. Circulation 104(17 Supplement): II 631, October 23, 2001

Preprocedural levels of acute phase reactants predict an aggressive clinical pattern of restenosis following coronary angioplasty. Journal of the American College of Cardiology 39(5 Supplement A): 31A, March 6, 2002

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. Journal of the American College of Cardiology 34(5): 1512-1521, 1999

Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent. Angiology 68(2): 177, 2016

Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 108(22): 2776-2782, 2003

Residual stenosis following coronary stenting does not predict restenosis in the strecker stent. European Heart Journal 14(ABSTR SUPPL ): 290, 1993